GM1 gangliosidosis type II: Results of a 10-year prospective study. [PDF]
D'Souza P +28 more
europepmc +1 more source
Real-time MR tracking of AAV gene therapy with βgal-responsive MR probe in a murine model of GM1-gangliosidosis. [PDF]
Taghian T +16 more
europepmc +1 more source
Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model. [PDF]
Liu S, Xie T, Huang Y.
europepmc +1 more source
Case report: Preimplantation genetic testing for infantile GM1 gangliosidosis. [PDF]
Zagaynova VA +12 more
europepmc +1 more source
Corrigendum to "Natural history progression of MRI brain volumetrics in type II late-infantile and juvenile GM1 gangliosidosis patients" [Molecular Genetics and Metabolism 2025 Mar;144(3):109025]. [PDF]
Kolstad J +18 more
europepmc +1 more source
A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE). [PDF]
Héron B +9 more
europepmc +1 more source
Novel insights into pathomechanisms of retinal neuronal degeneration and reactive gliosis in a murine model of G<sub>M1</sub>-gangliosidosis. [PDF]
Jubran L +5 more
europepmc +1 more source
Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis. [PDF]
Quadrini KJ +9 more
europepmc +1 more source

